Company intelligence / Profile preview

Finesco SAS

France

Ownership: Private
Development stage: Other

Overview

Finesco SAS was a contract sales organization (CSO) providing services for third-party pharmaceutical companies in France, with over 80 sales representatives. It was acquired by Apricus Biosciences on July 12, 2012, and its financing ceased in March 2013 due to changes in French reimbursement policies.

Industry: Consulting

Beyond the preview

Go deeper on Finesco SAS.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Finesco SAS.

Explore the full profile